Key facts
| Price (PPV) | 183.10 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | azilsartan |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09CA09 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Boite de 28 |
| Hospital price | 114.40 MAD |
| Data collected on | 9/8/2026 |
Indications
Edarbi est indiqué dans le traitement de l’hypertension artérielle essentielle chez l’adulte
Find an open pharmacy
On-call pharmacies near you
About Edarbi 80 mg
Edarbi 80 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Edarbi 80 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Edarbi 80 mg
Answers to common questions from Moroccan patients about this drug.